digital therapeutics Archives - MedCity News https://medcitynews.com/tag/digital-therapeutics/ Healthcare technology news, life science current events Tue, 26 Sep 2023 11:28:11 +0000 en-US hourly 1 https://wordpress.org/?v=6.3.1 https://medcitynews.com/uploads/2021/03/cropped-mblue-32x32.png digital therapeutics Archives - MedCity News https://medcitynews.com/tag/digital-therapeutics/ 32 32 40682243 Digital Therapeutics: A Panacea for Care or Overvalued Health Tech? https://medcitynews.com/2023/09/digital-therapeutics-a-panacea-for-care-or-overvalued-health-tech/ https://medcitynews.com/2023/09/digital-therapeutics-a-panacea-for-care-or-overvalued-health-tech/#respond Tue, 26 Sep 2023 11:30:39 +0000 https://medcitynews.com/?p=649368 therapeutics

Digital therapeutics will be one of the topics discussed at INVEST Digital Health scheduled for October 26 at Health Wildcatters headquarters in Pegasus Park in Dallas. Register today!

]]>
https://medcitynews.com/2023/09/digital-therapeutics-a-panacea-for-care-or-overvalued-health-tech/feed/ 0 649368
Click Expands to Substance Use Disorder With Indivior Digital Therapeutics Pact https://medcitynews.com/2023/09/digital-therapeutic-substance-use-disorder-indivior-click-therapeutics/ https://medcitynews.com/2023/09/digital-therapeutic-substance-use-disorder-indivior-click-therapeutics/#respond Sun, 10 Sep 2023 12:36:14 +0000 https://medcitynews.com/?p=648099

Digital therapeutics developer Click Therapeutics is partnering with Indivior to develop a mobile app for substance use disorder. Indivior is now Click’s third development partner, following deals with Boehringer Ingelheim and Otsuka Pharmaceutical.

]]>
https://medcitynews.com/2023/09/digital-therapeutic-substance-use-disorder-indivior-click-therapeutics/feed/ 0 648099
Rigorous Data Are Key to Convince Payers, Investors in the World of Digital Therapeutics https://medcitynews.com/2023/07/rigorous-data-are-key-to-convince-payers-investors-in-the-world-of-digital-therapeutics/ https://medcitynews.com/2023/07/rigorous-data-are-key-to-convince-payers-investors-in-the-world-of-digital-therapeutics/#respond Tue, 25 Jul 2023 22:06:56 +0000 https://medcitynews.com/?p=642378

Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers.

]]>
https://medcitynews.com/2023/07/rigorous-data-are-key-to-convince-payers-investors-in-the-world-of-digital-therapeutics/feed/ 0 642378
What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder https://medcitynews.com/2023/06/what-pear-therapeutics-bankruptcy-has-left-the-dtx-industry-to-ponder/ https://medcitynews.com/2023/06/what-pear-therapeutics-bankruptcy-has-left-the-dtx-industry-to-ponder/#respond Mon, 12 Jun 2023 22:35:10 +0000 https://medcitynews.com/?p=635845

One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested […]

]]>
https://medcitynews.com/2023/06/what-pear-therapeutics-bankruptcy-has-left-the-dtx-industry-to-ponder/feed/ 0 635845
In Therapeutic Innovation, Digital Must Be Held to the Same Rigor as Biotech https://medcitynews.com/2023/05/in-therapeutic-innovation-digital-must-be-held-to-the-same-rigor-as-biotech/ https://medcitynews.com/2023/05/in-therapeutic-innovation-digital-must-be-held-to-the-same-rigor-as-biotech/#respond Tue, 30 May 2023 05:40:55 +0000 https://medcitynews.com/?p=633711

The challenge of introducing a novel therapy is nothing new. It has been done again and again, but always from a foundation of compelling evidence…gathered through a rigorous scientific approach that demonstrates quality, safety, efficacy, and a favorable balance of benefits and risks.

]]>
https://medcitynews.com/2023/05/in-therapeutic-innovation-digital-must-be-held-to-the-same-rigor-as-biotech/feed/ 0 633711
Why Sofinnova is Betting on the Confluence of Digital Technology and the Life Sciences https://medcitynews.com/2023/04/why-sofinnova-is-betting-on-the-confluence-of-digital-technology-and-the-life-sciences/ https://medcitynews.com/2023/04/why-sofinnova-is-betting-on-the-confluence-of-digital-technology-and-the-life-sciences/#respond Tue, 04 Apr 2023 23:07:54 +0000 https://medcitynews.com/?p=630159

Paris-based Sofinnova Partners announced last week that it has launched a new strategy aimed at investing in a new breed of startups that straddle the lines between data and biology.

]]>
https://medcitynews.com/2023/04/why-sofinnova-is-betting-on-the-confluence-of-digital-technology-and-the-life-sciences/feed/ 0 630159
AppliedVR Earns First Unique CMS Code Ever Granted to a Digital Therapeutic https://medcitynews.com/2023/03/appliedvr-earns-first-unique-cms-code-ever-granted-to-a-digital-therapeutic/ https://medcitynews.com/2023/03/appliedvr-earns-first-unique-cms-code-ever-granted-to-a-digital-therapeutic/#respond Wed, 22 Mar 2023 20:31:18 +0000 https://medcitynews.com/?p=628638

CMS recently established a unique code for AppliedVR’s flagship product, marking the first time a digital therapeutic or immersive therapeutic has ever been placed in an existing benefit category. The eight-week program is a physician-prescribed solution that allows patients to manage their chronic lower back pain without opioids from the comfort of their own home.

]]>
https://medcitynews.com/2023/03/appliedvr-earns-first-unique-cms-code-ever-granted-to-a-digital-therapeutic/feed/ 0 628638
Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps https://medcitynews.com/2023/03/pear-therapeutics-cuts-are-not-enough-strategic-alternatives-among-next-steps/ https://medcitynews.com/2023/03/pear-therapeutics-cuts-are-not-enough-strategic-alternatives-among-next-steps/#respond Sun, 19 Mar 2023 17:36:29 +0000 https://medcitynews.com/?p=627999

Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking strategic alternatives for the business. Prospective buyers can pick up Pear’s FDA-cleared products for substance use disorder, opioid use disorder, and insomnia.

]]>
https://medcitynews.com/2023/03/pear-therapeutics-cuts-are-not-enough-strategic-alternatives-among-next-steps/feed/ 0 627999
The Drive to Adopt Digital Therapeutics: Where do we Stand? https://medcitynews.com/2023/03/the-drive-to-adopt-digital-therapeutics-where-do-we-stand/ https://medcitynews.com/2023/03/the-drive-to-adopt-digital-therapeutics-where-do-we-stand/#respond Sat, 04 Mar 2023 00:10:07 +0000 https://medcitynews.com/?p=622024

As regulatory processes and reimbursements are refined, there needs to be a continued focus on how to maximize the benefits for patients and ensure DTx can play a role in improving outcomes. The key to this is integration into the clinical workflow.

]]>
https://medcitynews.com/2023/03/the-drive-to-adopt-digital-therapeutics-where-do-we-stand/feed/ 0 622024
The Challenges, Potential, and Future of Digital Therapeutics in Healthcare https://medcitynews.com/2022/12/the-challenges-potential-and-future-of-digital-therapeutics-in-healthcare/ https://medcitynews.com/2022/12/the-challenges-potential-and-future-of-digital-therapeutics-in-healthcare/#respond Tue, 27 Dec 2022 12:04:47 +0000 https://medcitynews.com/?p=615313

Earlier this year, CMS implemented a new Level II Healthcare Common Procedure Coding System (HCPCS) code for “prescription digital behavioral therapy,” which makes it easier for commercial and Medicaid plans to cover these therapies. Additionally

]]>
https://medcitynews.com/2022/12/the-challenges-potential-and-future-of-digital-therapeutics-in-healthcare/feed/ 0 615313
RTM Reimbursement Represents a New Age for Digital Therapeutics https://medcitynews.com/2022/12/rtm-reimbursement-represents-a-new-age-for-digital-therapeutics/ https://medcitynews.com/2022/12/rtm-reimbursement-represents-a-new-age-for-digital-therapeutics/#respond Wed, 21 Dec 2022 18:40:54 +0000 https://medcitynews.com/?p=615343

Ultimately, it is anticipated that CMS will further expand the use of reimbursable RTM beyond respiratory and MSK care and incorporate patient-reported information as a requirement for reimbursement of certain remote services.

]]>
https://medcitynews.com/2022/12/rtm-reimbursement-represents-a-new-age-for-digital-therapeutics/feed/ 0 615343
How pharma companies can leverage asynchronous telemedicine https://medcitynews.com/2022/10/how-pharma-companies-can-leverage-asynchronous-telemedicine/ https://medcitynews.com/2022/10/how-pharma-companies-can-leverage-asynchronous-telemedicine/#respond Tue, 25 Oct 2022 19:09:08 +0000 https://medcitynews.com/?p=605725 therapeutics

Through apps, pharmaceutical companies can actually influence patient adherence and mindset after that patient has been prescribed that company’s medication by their physician.

]]>
https://medcitynews.com/2022/10/how-pharma-companies-can-leverage-asynchronous-telemedicine/feed/ 0 605725
Why better heart health worldwide is now within reach https://medcitynews.com/2022/08/why-better-heart-health-worldwide-is-now-within-reach/ https://medcitynews.com/2022/08/why-better-heart-health-worldwide-is-now-within-reach/#respond Wed, 10 Aug 2022 17:33:53 +0000 https://medcitynews.com/?p=594395

By placing the power to detect atrial fibrillation into the hands of 6 billion global smartphone users, validation of further physiological parameters will be expedited and the subsequent adoption of this technology into DTx will enable the low-cost tools required to remove barriers to care and improve heart health across the globe.

]]>
https://medcitynews.com/2022/08/why-better-heart-health-worldwide-is-now-within-reach/feed/ 0 594395
Overcoming obstacles in digital medicine https://medcitynews.com/2022/07/overcoming-obstacles-in-digital-medicine/ https://medcitynews.com/2022/07/overcoming-obstacles-in-digital-medicine/#respond Wed, 27 Jul 2022 22:35:14 +0000 https://medcitynews.com/?p=597131

A panel discussion on the future of digital medicine highlighted some of the collaborations taking place between pharma companies and digital health, as well as some of the challenges facing the push towards mainstream implementation.

]]>
https://medcitynews.com/2022/07/overcoming-obstacles-in-digital-medicine/feed/ 0 597131
A call to action for pharma manufacturers: Rise to the challenge of global medicine access with the help of digitalization https://medcitynews.com/2022/06/a-call-to-action-for-pharma-manufacturers-rise-to-the-challenge-of-global-medicine-access-with-the-help-of-digitalization/ https://medcitynews.com/2022/06/a-call-to-action-for-pharma-manufacturers-rise-to-the-challenge-of-global-medicine-access-with-the-help-of-digitalization/#respond Fri, 10 Jun 2022 15:31:20 +0000 https://medcitynews.com/?p=591029

Operational efficiency and visibility brought on by digital transformation can help improve how pharmaceutical manufacturers do their critical part in improving equitable access and availability of medicine around the world.

]]>
https://medcitynews.com/2022/06/a-call-to-action-for-pharma-manufacturers-rise-to-the-challenge-of-global-medicine-access-with-the-help-of-digitalization/feed/ 0 591029
The outlook for tech-enabled personalized care in healthcare and life sciences [Sponsored] https://medcitynews.com/2022/05/the-outlook-for-tech-enabled-personalized-care-in-healthcare-and-life-sciences/ https://medcitynews.com/2022/05/the-outlook-for-tech-enabled-personalized-care-in-healthcare-and-life-sciences/#respond Wed, 18 May 2022 16:57:48 +0000 https://medcitynews.com/?p=586089

A webinar sponsored by Twilio will share predictions for driving personalized care and engagement in healthcare and life sciences in 2022.

]]>
https://medcitynews.com/2022/05/the-outlook-for-tech-enabled-personalized-care-in-healthcare-and-life-sciences/feed/ 0 586089
Biofourmis adds $300M to ramp up in virtual care, digital therapy clinical trials https://medcitynews.com/2022/04/biofourmis-adds-300m-to-ramp-up-in-virtual-care-digital-therapy-clinical-trials/ https://medcitynews.com/2022/04/biofourmis-adds-300m-to-ramp-up-in-virtual-care-digital-therapy-clinical-trials/#respond Tue, 26 Apr 2022 15:32:27 +0000 https://medcitynews.com/?p=584517

The Series D round of funding makes Biofourmis a unicorn valued at $1.3 billion. CEO and founder Kuldeep Singh Rajput said that the new capital will be used to expand his company’s remote-monitoring technologies and continue development of digital therapeutics, both as companions to traditional drugs and as monotherapies.

]]>
https://medcitynews.com/2022/04/biofourmis-adds-300m-to-ramp-up-in-virtual-care-digital-therapy-clinical-trials/feed/ 0 584517
New study shows first FDA-cleared video game treatment for pediatric ADHD improves brain function https://medcitynews.com/2022/03/new-study-shows-first-fda-cleared-video-game-treatment-for-pediatric-adhd-improves-brain-function/ https://medcitynews.com/2022/03/new-study-shows-first-fda-cleared-video-game-treatment-for-pediatric-adhd-improves-brain-function/#respond Thu, 03 Mar 2022 04:13:49 +0000 https://medcitynews.com/?p=574017

In the U.S., EndeavorRx has been cleared to help in improving attention function as measured by computer-based testing in children ages 8-12 years who have primarily inattentive or combined-type ADHD who struggle with maintaining attention.

]]>
https://medcitynews.com/2022/03/new-study-shows-first-fda-cleared-video-game-treatment-for-pediatric-adhd-improves-brain-function/feed/ 0 574017
Pear’s digital therapeutic for alcohol use disorder gets breakthrough designation  https://medcitynews.com/2021/11/pears-digital-therapeutic-for-alcohol-use-disorder-gets-breakthrough-designation/ https://medcitynews.com/2021/11/pears-digital-therapeutic-for-alcohol-use-disorder-gets-breakthrough-designation/#respond Tue, 23 Nov 2021 16:46:38 +0000 https://medcitynews.com/?p=559802

The company got a breakthrough device designation for its app-based program for alcohol use disorder, reset-A. Pear currently has FDA-cleared digital therapeutics to address opioid use and substance use disorders.

]]>
https://medcitynews.com/2021/11/pears-digital-therapeutic-for-alcohol-use-disorder-gets-breakthrough-designation/feed/ 0 559802
Click Therapeutics raises $52M, looks to advance digital therapeutics https://medcitynews.com/2021/10/click-therapeutics-raises-52m-looks-to-advance-digital-therapeutics/ https://medcitynews.com/2021/10/click-therapeutics-raises-52m-looks-to-advance-digital-therapeutics/#respond Mon, 25 Oct 2021 23:03:29 +0000 https://medcitynews.com/?p=555557

Click Therapeutics is developing digital therapeutics for depression, insomnia and other conditions. It plans to use the funds to commercialize its therapeutics, through partnerships with pharmaceutical companies including Otsuka.

]]>
https://medcitynews.com/2021/10/click-therapeutics-raises-52m-looks-to-advance-digital-therapeutics/feed/ 0 555557
Investors see promise in digital health — the challenge is adoption https://medcitynews.com/2021/09/investors-see-promise-in-digital-health-the-challenge-is-adoption/ https://medcitynews.com/2021/09/investors-see-promise-in-digital-health-the-challenge-is-adoption/#respond Wed, 22 Sep 2021 19:29:59 +0000 https://medcitynews.com/?p=550628

VCs at MedCity INVEST Digital Health said there’s no shortage of interesting digital health companies, even ones that can prove their innovations are effective. The challenge is winning over insurers and physicians, and finding payment models that work. 

]]>
https://medcitynews.com/2021/09/investors-see-promise-in-digital-health-the-challenge-is-adoption/feed/ 0 550628
Startup testing video-based treatment for ‘lazy eye’ touts Phase 3 results https://medcitynews.com/2021/09/startup-testing-video-based-treatment-for-lazy-eye-touts-phase-3-results/ https://medcitynews.com/2021/09/startup-testing-video-based-treatment-for-lazy-eye-touts-phase-3-results/#respond Tue, 14 Sep 2021 15:08:27 +0000 https://medcitynews.com/?p=549203

Luminopia, a startup with a digital therapeutic for amblyopia, or lazy eye, recently published the results of a phase 3 study showing its TV-based treatment can improve vision in kids’ non-dominant eye. Patients don a headset where images are altered to make them use both eyes. 

]]>
https://medcitynews.com/2021/09/startup-testing-video-based-treatment-for-lazy-eye-touts-phase-3-results/feed/ 0 549203
Neuroglee looks to Mayo partnership, digital therapeutics to tackle mild cognitive impairment https://medcitynews.com/2021/09/neuroglee-looks-to-mayo-partnership-digital-therapeutics-to-tackle-mild-cognitive-impairment/ https://medcitynews.com/2021/09/neuroglee-looks-to-mayo-partnership-digital-therapeutics-to-tackle-mild-cognitive-impairment/#respond Thu, 09 Sep 2021 10:45:17 +0000 https://medcitynews.com/?p=548690

Neuroglee recently raised $10 million in funding and struck a partnership with Mayo Clinic. It’s building a digital therapeutic and virtual programs for people with mild cognitive impairment. 

]]>
https://medcitynews.com/2021/09/neuroglee-looks-to-mayo-partnership-digital-therapeutics-to-tackle-mild-cognitive-impairment/feed/ 0 548690
Big Health tests if insomnia app can help with anxiety, depression https://medcitynews.com/2021/09/big-health-tests-if-insomnia-app-can-help-with-anxiety-depression/ https://medcitynews.com/2021/09/big-health-tests-if-insomnia-app-can-help-with-anxiety-depression/#respond Wed, 01 Sep 2021 22:00:16 +0000 https://medcitynews.com/?p=547631

The company recently finished a study showing patients in the U.K. who used both Sleepio’s app and therapy saw improvements in anxiety and depression compared to people who used therapy alone. But the study also had several limitations. 

]]>
https://medcitynews.com/2021/09/big-health-tests-if-insomnia-app-can-help-with-anxiety-depression/feed/ 0 547631
AppliedVR, Curebase to launch five studies of VR for chronic pain  https://medcitynews.com/2021/08/appliedvr-curebase-to-launch-five-studies-of-vr-for-chronic-pain/ https://medcitynews.com/2021/08/appliedvr-curebase-to-launch-five-studies-of-vr-for-chronic-pain/#respond Fri, 27 Aug 2021 00:08:59 +0000 https://medcitynews.com/?p=546827

The startup is working with Curebase to launch five clinical trials to test its VR-based therapeutic for chronic pain. They plan to enroll a total of more than 2,000 people.

]]>
https://medcitynews.com/2021/08/appliedvr-curebase-to-launch-five-studies-of-vr-for-chronic-pain/feed/ 0 546827
Akili strikes $37.5M licensing deal for another game-based treatment https://medcitynews.com/2021/08/akili-strikes-37-5m-licensing-deal-for-another-game-based-treatment/ https://medcitynews.com/2021/08/akili-strikes-37-5m-licensing-deal-for-another-game-based-treatment/#respond Thu, 19 Aug 2021 16:09:23 +0000 https://medcitynews.com/?p=545381

The company is licensing out technology from Australian digital health company TALi Digital to improve attention in early childhood. Akili will pay $37.5 million, including milestone payments and royalties. 

]]>
https://medcitynews.com/2021/08/akili-strikes-37-5m-licensing-deal-for-another-game-based-treatment/feed/ 0 545381
Report: Digital health tools maturing as research, funding grows  https://medcitynews.com/2021/08/report-digital-health-tools-maturing-as-research-funding-grows/ https://medcitynews.com/2021/08/report-digital-health-tools-maturing-as-research-funding-grows/#respond Tue, 03 Aug 2021 23:31:46 +0000 https://medcitynews.com/?p=543338

Consumers and benefits managers have a record number of digital health tools to choose from, according to a new report by the IQVIA Institute for Human Data Science. 

]]>
https://medcitynews.com/2021/08/report-digital-health-tools-maturing-as-research-funding-grows/feed/ 0 543338
CEO of digital therapeutics business Freespira talks about its approach to anxiety disorders https://medcitynews.com/2021/07/freespira-digital-therapeutics-and-anxiety-disorders/ https://medcitynews.com/2021/07/freespira-digital-therapeutics-and-anxiety-disorders/#respond Tue, 27 Jul 2021 20:16:59 +0000 https://medcitynews.com/?p=542303

Freespira CEO Dean Sawyer said its FDA cleared digital therapeutic is the first that’s proven to significantly reduce or eliminate symptoms of panic attacks, panic disorder, and PTSD, in a single, 28-day treatment episode.

]]>
https://medcitynews.com/2021/07/freespira-digital-therapeutics-and-anxiety-disorders/feed/ 0 542303
Without judgment: How digital therapeutics is destigmatizing mental health treatment https://medcitynews.com/2021/07/without-judgment-how-digital-therapeutics-is-destigmatizing-mental-health-treatment/ https://medcitynews.com/2021/07/without-judgment-how-digital-therapeutics-is-destigmatizing-mental-health-treatment/#respond Tue, 20 Jul 2021 19:00:17 +0000 https://medcitynews.com/?p=540593

DTx helps reduce mental health stigma that is a barrier for underrepresented populations to receiving mental health care and if developed with intention and within a culturally-responsive framework, DTx won’t judge or discriminate.

]]>
https://medcitynews.com/2021/07/without-judgment-how-digital-therapeutics-is-destigmatizing-mental-health-treatment/feed/ 0 540593
Pear Therapeutics plans to go public in $1.6B SPAC deal https://medcitynews.com/2021/06/pear-therapeutics-plans-to-go-public-in-1-6b-spac-deal/ https://medcitynews.com/2021/06/pear-therapeutics-plans-to-go-public-in-1-6b-spac-deal/#respond Tue, 22 Jun 2021 23:27:51 +0000 https://medcitynews.com/?p=536852

Digital therapeutics startup Pear Therapeutics struck a deal to go public through a blank-check acquisition that would value the company at $1.6B. But it still faces big challenges in selling its app-based treatments. 

]]>
https://medcitynews.com/2021/06/pear-therapeutics-plans-to-go-public-in-1-6b-spac-deal/feed/ 0 536852